Researchers have found that a leukemia drug may help in stroke treatment. A drug called TPA is widely used to treat stroke patients, but with two concerns it can cause dangerous bleeding in the brain, and it has just a three-hour window to reverse the damage from a stroke. So time is critical.
But now, in animal studies, researchers have found that the leukemia drug, Gleevec, can block TPA's bleeding risk and also extend that window of time for a stroke victim to get help. Researchers in Sweden will soon begin a clinical trial to test the theory in humans.